1. Acknowledgement to Referees

   Acknowledgement to Referees 19 November 2015 Pages: 2051 - 2055

2. The Challenges of Interstitial Cystitis: Current Status and Future Prospects

   • Samuel Belknap
   • Eric Blalock
   • Deborah Erickson

   Current Opinion 24 November 2015 Pages: 2057 - 2063

3. Disease-Modifying Drugs in Parkinson’s Disease

   • Ariane Park
   • Mark Stacy

   Leading Article 18 November 2015 Pages: 2065 - 2071

4. Lipoglycopeptide Antibacterial Agents in Gram-Positive Infections: A Comparative Review

   • Françoise Van Bambeke

   Review Article 24 November 2015 Pages: 2073 - 2095

   

5. Complicated Intra-Abdominal Infections: The Old Antimicrobials and the New Players

   • Young R. Lee
   • Danni McMahan
   • Gregory K. Perry

   Review Article 26 November 2015 Pages: 2097 - 2117

6. Adalimumab: A Review in Chronic Plaque Psoriasis

   • Celeste B. Burness
   • Kate McKeage

   Adis Drug Evaluation 19 November 2015 Pages: 2119 - 2130

7. Netupitant/Palonosetron: A Review in the Prevention of Chemotherapy-Induced Nausea and Vomiting

   • Gillian M. Keating

   Adis Drug Evaluation 27 November 2015 Pages: 2131 - 2141

8. Lacosamide: A Review in Focal Seizures in Patients with Epilepsy

   • Lesley J. Scott

   Adis Drug Evaluation 25 November 2015 Pages: 2143 - 2154

   

9. Idarucizumab: First Global Approval

   • Celeste B. Burness

   AdisInsight Report 17 November 2015 Pages: 2155 - 2161

   

10. Mepolizumab: First Global Approval

    • Gillian M. Keating

    AdisInsight Report 24 November 2015 Pages: 2163 - 2169

    

11. Erratum to: Pharmacologic Targeting of Regulatory T Cells for Solid Organ Transplantation: Current and Future Prospects

    • Kassem Safa
    • Sindhu Chandran
    • David Wojciechowski

    Erratum 09 November 2015 Pages: 2171 - 2171